Search Results - HENITZ, Erin D

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib―Rituximab Versus Rituximab

    Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib―Rituximab Versus Rituximab by COIFFIER, Bertrand, WEIMIN LI, SCHAFFER, Michael E, OSMANOV, Evgenii A, XIAONAN HONG, SCHELIGA, Adriana, MAYER, Jiri, OFFNER, Fritz, RULE, Simon, TEIXEIRA, Adriana, ROMEJKO-JAROSINSKA, Joanna, DE VOS, Sven, HENITZ, Erin D, CRUMP, Michael, SHPILBERG, Ofer, ZINZANI, Pier Luigi, CAKANA, Andrew, ESSELTINE, Dixie-Lee, MULLIGAN, George, RICCI, Deborah, KARKERA, Jayaprakash D, FAVIS, Reyna, GAFFNEY, Dana, SHAPIRO, Alice, THEOCHAROUS, Panteli, ELSAYED, Yusri A, VAN DE VELDE, Helgi

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory Follicular Lymphoma (FL): Biomarker Analyses of the Phase 3 LYM3001 Study

    Identification of Patient Subgroups Demonstrating Longer Progression-Free Survival (PFS) Benefit with Bortezomib-Rituximab Versus Rituximab in Patients with Relapsed or Refractory... by Coiffier, Bertrand, Li, Weimin, Henitz, Erin D, Karkera, J.D., Favis, Reyna, Gaffney, Dana, Shapiro, Alice, Theocharous, Panteli, Elsayed, Yusri A, van de Velde, Helgi, Osmanov, Evgenii A, Hong, Xiaonan, Scheliga, Adriana, Offner, Fritz C., Rule, Simon, Teixeira, Adriana C, Walewski, Jan, de Vos, Sven, Crump, Michael, Shpilberg, Ofer, Zinzani, Pier Luigi, Cakana, Andrew Z, Esseltine, Dixie-Lee, Mulligan, George, Ricci, Deborah S

    Published in Blood
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: